MENU
IGC
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
IGC Pharma (IGC) Ownership - Who owns IGC Pharma?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.06M
P/E Ratio
N/A
Total Cash
912K
Projected Growth
N/A
Total Debt
345K
Revenue
N/A
Risk (Beta)
0.25
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
15.73
Revenue/Share
0.02 USD as % of share price
Fundamentals
IGC
Capitalization
27.1M
P/E Ratio
N/A
Risk (Beta)
0.25
Dividend Yield
N/A
Total Cash
912K
Total Cash/Share
0.01
Total Debt
345K
Total Debt/Equity
15.73
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
N/A
ROE
N/A
Book Value
7.32M
P/B Ratio
3.43
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
124M
Current Ratio
1.58
Current Revenue Per Employee
4402.98
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
57.97
Revenue To Assets
N/A
Shares Held By Institutions
1.43M
Shares Outstanding - Current
75.6M
Total Liabilities
2.58M
Total Volume MTD
N/A
Value
N/A
Gain YTD
27.704
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us